IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT07441174 · RECRUITING
Trial details
- NCT number
- NCT07441174
- Sponsor
- InxMed (Shanghai) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-28
- Primary completion
- 2031-02-28
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.